Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Fecal immunochemical tests for post-polypectomy colorectal cancer surveillance may reduce the need for colonoscopy and improve screening adherence. Stool-based post-polypectomy surveillance strategies ...

New Study Shows at-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death, as Effective as Screening Colonoscopy July 25, 2024 — A noninvasive colorectal cancer screening test ...

Let’s start with the cheapest, the yearly FIT, or fecal immunochemical test, which looks for fecal blood that might be caused ...

A new study analysed the efficacy of blood tests versus colonoscopies and stool tests in identifying early-stage CRC. Read ...

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

There's a new blood test to screen for colorectal cancer, but a new study found it's not as effective as a colonoscopy or ...

Colorectal cancer is the second leading cause of cancer-related deaths among men and women when rates are combined. While ...